Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...
Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...
39mon MSN
Dementia myths that delay diagnosis
Can’t remember what you needed to buy when out for grocery shopping? Or need a minute to pinpoint the immediate neighbor’s ...
However, lecanemab doesn’t stop the relentless march of Alzheimer’s disease, it just slows it down. The medication, sold under the brand name Leqembi, also comes with a hefty price tag and a risk of ...
Sportschosun on MSN
Ari Bio will participate in BioEurope in 2025 next month...There's a lot of interest in Alzheimer's ...
Aribio (CEO Jeong Jae-joon) announced that it will participate in the world's largest bio-partnering conference 'Bio-Europe ...
Sportschosun on MSN
Dementia-induced sleep apnea causes decreased brain waste discharge function
The relationship between sleep apnea severity and brain waste discharge system'Agyrolimp system'activity. The more severe ...
The biotechnology firm developing treatments for neurological disorders sold 14.75 million shares Sunday for $17 each, according to a statement. Affiliates of funds managed by Goldman Sachs Group Inc.
Parkinson’s disease and Lewy Body Dementia (LBD) are brain diseases that affect millions of people in the United States. They ...
October is National Protect Your Hearing Month, and a recent study is linking untreated hearing loss with dementia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback